| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/09/2002 | EP1169047A1 Compositions and methods for treatment of diabetes |
| 01/09/2002 | EP1169046A1 Pulmonary delivery of protonated/acidified nucleic acids |
| 01/09/2002 | EP1169045A2 Immunomodulating polymers |
| 01/09/2002 | EP1169044A1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence |
| 01/09/2002 | EP1169043A1 Use of estrogens and delta-gonadien-21-ol-3,20-diones |
| 01/09/2002 | EP1169042A1 Dibenzo-azepine derivatives as alpha v integrin receptor antagonists |
| 01/09/2002 | EP1169041A2 Use of carbamic acid derivatives for the treatment of viral infections |
| 01/09/2002 | EP1169040A2 Flupirtine in the treatment of fibromyalgia and related conditions |
| 01/09/2002 | EP1169039A2 Pharmaceutical formulation comprising amoxycillin |
| 01/09/2002 | EP1169038A1 Cyclic protein tyrosine kinase inhibitors |
| 01/09/2002 | EP1169037A2 Use of insulin sensitisers for improving ketosis |
| 01/09/2002 | EP1169036A2 Anti-viral uses of leflunomide products |
| 01/09/2002 | EP1169034A1 Decursinol or derivative thereof as analgesic agent |
| 01/09/2002 | EP1169033A2 Enhanced tissue and subcellular delivery of vitamin e compounds |
| 01/09/2002 | EP1169032A1 Ketoprofen microgranules, method for preparing same and pharmaceutical compositions |
| 01/09/2002 | EP1169031A1 Antimicrobial agents |
| 01/09/2002 | EP1169030A1 Agents and methods for promoting production gains in animals |
| 01/09/2002 | EP1169029A1 Method of treating sleep apnoea |
| 01/09/2002 | EP1169028A1 Treatment of hiatial hernia |
| 01/09/2002 | EP1169027A1 Treatment of osteoarthritis |
| 01/09/2002 | EP1169026A2 Use of ap-1 activators to treat glaucoma and ocular hypertension |
| 01/09/2002 | EP1169025A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 01/09/2002 | EP1169024A1 Pregelatinized starch in a controlled release formulation |
| 01/09/2002 | EP1169021A1 Compositions and methods for treating lymphoma |
| 01/09/2002 | EP1169019A1 Pharmaceutical aerosol formulation |
| 01/09/2002 | EP1169005A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 01/09/2002 | EP1168934A1 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 01/09/2002 | EP1168931A1 Method of using emamectin to treat fish parasites |
| 01/09/2002 | EP1168920A1 (s)-enantiomer enriched fipronil composition |
| 01/09/2002 | EP1168919A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1168912A1 Organ arrest, protection and preservation |
| 01/09/2002 | EP1049461B1 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction |
| 01/09/2002 | EP0996617B1 2,4-Dithi(oxo)-pyridin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists |
| 01/09/2002 | EP0986569A4 Process for preparing etoposide |
| 01/09/2002 | EP0970042B1 5-hydroxymethyl-2-aminotetralins as cardiovascular agents |
| 01/09/2002 | EP0937072B1 THIENYLCYCLOHEXANONE DERIVATIVES AS LIGANDS OF THE GABA A alpha5 RECEPTOR SUBTYPE |
| 01/09/2002 | EP0918768B1 Aromatic amidine derivatives useful as selective thrombin inhibitors |
| 01/09/2002 | EP0866806A4 Method of mobilizing hematopoietic stem cells |
| 01/09/2002 | EP0783398B1 Razor cartridges comprising wound healing compositions |
| 01/09/2002 | EP0765151B1 Antibacterial oil-in-water emulsions |
| 01/09/2002 | EP0727978B1 Topical aromatic releasing compositions |
| 01/09/2002 | EP0607439B1 Nitrogenous heterocyclic compound |
| 01/09/2002 | EP0585328B1 Substituted 3-aminoquinuclidines |
| 01/09/2002 | CN1330664A Platelet-derived growth factor C, DNA coding therefor and uses thereof |
| 01/09/2002 | CN1330659A Pregnane glucuronides compound |
| 01/09/2002 | CN1330658A Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 01/09/2002 | CN1330655A Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/09/2002 | CN1330654A 4,5-pyrrolo-oxindoles |
| 01/09/2002 | CN1330653A 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 01/09/2002 | CN1330652A 2,3,4,4-tetrahydro-1H-pyrazino (1,2-a) quinoxalin-5(6H) one deivatives being 5HT2C agonists |
| 01/09/2002 | CN1330650A Dibenz [a.g] quinolizinium derivatives and salts thereof |
| 01/09/2002 | CN1330648A 4-aryloxindoles as inhibitor of JNK protein kinases |
| 01/09/2002 | CN1330647A 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2 |
| 01/09/2002 | CN1330643A IL-5 inhibiting azauracil pyrimidine derivatives |
| 01/09/2002 | CN1330642A N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, irreversible inihibotr of tyrosine kinases |
| 01/09/2002 | CN1330641A Crystalline forms of 3-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-3H-benzimidzole-5-carboxamide |
| 01/09/2002 | CN1330640A Cyclic hydrazine derivatives as TNF-alpha inhibitors |
| 01/09/2002 | CN1330638A Substituted benzo (de) isoquinoline-1,3-diones |
| 01/09/2002 | CN1330636A Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5HT1A receptor activity |
| 01/09/2002 | CN1330634A Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| 01/09/2002 | CN1330631A Amide derivatives which are useful as cell factor inhibitors |
| 01/09/2002 | CN1330630A 7-aryl-6(z) heptantriene acid vitamin A amide as apoptosis inducing compounds and their use as anti-cancer agents |
| 01/09/2002 | CN1330629A Novel 2-akoxybenzylamine derivatives and their use as medicines for treating schizophrenia |
| 01/09/2002 | CN1330621A Method of vitamin production |
| 01/09/2002 | CN1330556A Combination therepy of angiotensin-converting enzyme inhibor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease |
| 01/09/2002 | CN1330550A Use of substances with oxytocin activity in order to create cell regeneration |
| 01/09/2002 | CN1330548A Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agents |
| 01/09/2002 | CN1330547A Pharmaceutical formulations |
| 01/09/2002 | CN1330546A Compositions comprising cefuroxime axetil |
| 01/09/2002 | CN1330545A Treating for skin disease |
| 01/09/2002 | CN1330544A Combination of cerivastatin and fibrates |
| 01/09/2002 | CN1330543A Compositions and methods for amelioration of human female sexual dysfunction |
| 01/09/2002 | CN1330542A Method and composition for maintanance and restitution gut integrity |
| 01/09/2002 | CN1330541A Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence |
| 01/09/2002 | CN1330540A Utilization of inhibitors of KQT1 channel in order to produce medicament for treating diseases which are caused by parasitic helminths and actoparasites |
| 01/09/2002 | CN1330539A Compositions and methods for treatment of anorectal disorders |
| 01/09/2002 | CN1330538A Stable pharmaceutical formulation comprising HMC-CoA reductase inhibitor |
| 01/09/2002 | CN1330537A Pharmaceutical mixed comprising profen |
| 01/09/2002 | CN1330536A Biodegradable polymer encapsulated 5-hydroxytryptamine receptor antagonist and method for preparing the same |
| 01/09/2002 | CN1330532A Oil-in-water emulsion comprising micronised biologically active agent and appropriate emulsified system |
| 01/09/2002 | CN1330073A Peptide nucleic acid derivatives, intermediate for preparing them and medicinal composition containing them |
| 01/09/2002 | CN1330069A Substituted 2-benzo [c] furanone compound, its preparing process and medicinal composition containing it |
| 01/09/2002 | CN1330067A 1,1-and 1,2-twice subsitituted cyclopropane compound, preparation method thereof and drug composite containing their |
| 01/09/2002 | CN1329925A Biologically cmposite artificial bone and its preparing process |
| 01/09/2002 | CN1329917A Medicine for treating Type-2 diabetes and its preparing process |
| 01/09/2002 | CN1329905A Concentrated granular medicine for treating baby's cough and asthma and its preparing process |
| 01/09/2002 | CN1329901A Exterior-applied black plaster for treating bone diseases and its preparing process |
| 01/09/2002 | CN1329896A Medical wine for treating rheumatism, rheumatoid diseases and hyperosteogeny |
| 01/09/2002 | CN1329890A Dual-layer slow releasing tablet of benproperine phosphate |
| 01/09/2002 | CN1329889A Concentrated granular medicine for treating baby cold and preparation process thereof |
| 01/09/2002 | CN1329888A Method for preparing medicine containing substitution pyridyl dihydric heptene acid or it salt |
| 01/09/2002 | CN1329887A Application of clonidine as analgesic |
| 01/09/2002 | CN1329886A Medical percutaneous preparation containing hydrophilic or salt form |
| 01/09/2002 | CN1077575C Camptothecin derivatives and their manufacturing method and its intermediate |
| 01/09/2002 | CN1077574C Tropane derivatives, their preparation and use |
| 01/09/2002 | CN1077573C Heterocycles useful as neurokinin antagonists |
| 01/09/2002 | CN1077572C 取代的吡咯 Substituted pyrrole |
| 01/09/2002 | CN1077571C Substituted bisindolylmaleimides for inhibition of cell proliferation |
| 01/09/2002 | CN1077570C Sulfamate compounds containing N-substituted carbanoyl and process for preparing the same |